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Introduction

Lehigh Valley Health Network, Allentown, Pennsylvania

Discussion

• Native vertebral osteomyelitis (NVO) is an
infection of the vertebrae
• Once diagnosed, antibiotics are prescribed
targeting the causative agent of infection
• Treatment is typically monitored by
concurrent ESR and CRP laboratory testing
• Importantly, the necessity of utilizing both
inflammatory markers concurrently is
unclear and Choosing Wisely guidance
suggests using both labs is redundant
• The primary aim of this study is to review
the utility of concurrent ESR and CRP
testing in NVO

Results

• The percent agreement between ESR and
CRP was 75.7 and the percent
disagreement was 24.3
• There was no statistically significant
difference in 30-day readmissions for
patients with concurrent ESR and CRP
testing when the results were in agreement
or disparate
• The data suggests that concurrent ESR and
CRP tests may not be necessary for
monitoring treatment of NVO

Methods
Inclusion and exclusion criteria were set up to
standardize the candidates in this study:
•
•
•
•
•

•
•

Inclusion
18 years or older
Admitted to LVH-CC or LVHM (8/1/15-7/31/17)
Received inpatient ID
consult
Diagnosed with NVO
Received outpatient
parental antimicrobial
therapy
Received IV/oral
antimicrobial therapy
At least one concurrent
testing of ESR and CRP

•
•
•

•
•

Exclusion
Lack of microbiological
diagnosis
Previous spinal
instrumentation (one year)
Spinal tuberculosis, spinal
brucellosis, NVO caused by
yeasts and molds and spinal
infections caused by seeding
from a local site of infection
Only one episode of NVO
will be included
Cases with possible culture
contaminants

ANOVA statistical analysis utilized to compare concurrent
ESR and CRP results to readmissions within 30 days.

Gender

Race

Ethnicity

Male
Female
Black or African American
Missing or Unavailable
Other
Patient declined or refused
Unknown
White or Caucasian
Hispanic or Latino
Not Hispanic or Latino
Patient Refused
Unknown

70.73%
29.27%
2.44%
2.44%
2.44%
2.44%
2.44%
87.80%
2.44%
87.80%
2.44%
7.32%

• 41 patients underwent 332 ESR and CRP tests (173
ESR, 159 CRP) during their treatment course
• Of the 148 ESR and CRP tests performed concurrently:
8.1% (12/148) of concurrent ESR/CRP tests were in
agreement for normal results, 67.6% (100/148) were in
agreement for abnormal results and 24.3% (36/148)
had disparate results
8%
Both normal
24%
Both abnormal
Disparate results

68%

• The average treatment course was 47 days (range, 36147): 46 days for disparate results, 50 days for
instances of agreement of abnormal results, and 44
days for instances of agreement of normal results
(p=NS)
• 19.5% (8/41) of patients experienced a 30-day hospital
readmission and underwent 32 instances of concurrent
ESR/CRP testing: 3.1% (1/32) instances were in
agreement for normal results, 75.0% (24/32) were in
agreement for abnormal results and 21.9% (7/32) had
disparate results (p=NS)

Conclusion

• Concurrent ESR and CRP tests for
monitoring treatment of NVO may not be
helpful
• A limitation of the data is the small sample
size and further research should be
performed on a larger sample size
• Additionally, further studies should extend
the follow-up period to one year to attempt
to capture more potential treatment failures
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